Skip to main content
HOLX
NASDAQ Industrial Applications And Services

Hologic Confirms Merger Terms and Employee Equity Treatment Ahead of Acquisition Close

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$74.86
Mkt Cap
$16.699B
52W Low
$51.9
52W High
$75.34
52W Position info
44% above low
Off High info
at 52W high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

HOLX sits 44% above its 52-week low of $51.9.

Summary

Hologic issued an internal FAQ to employees, detailing the cash and CVR consideration for its acquisition by Blackstone and TPG, and clarifying the treatment of employee equity awards.


Key Events · M&A and Partnerships · HOLX

  • Merger Terms Confirmed

    Shareholders will receive $76.00 per share in cash and one CVR for up to $3.00, contingent on Breast Health business revenue goals in fiscal years 2026 and 2027.

  • Equity Award Treatment Detailed

    Unvested RSUs granted before October 21, 2025, will be cashed out at closing ($76 + CVR). RSUs granted after that date will convert to unvested cash awards.

  • Stock Option Conversion

    Stock options with an exercise price below $76 will receive cash ($76 minus exercise price) plus a CVR. Options with an exercise price between $76 and $79 will receive an adjusted CVR, while options at or above $79 will be canceled.

  • ESPP Discontinuation

    The Hologic Employee Stock Purchase Plan (ESPP) will cease in calendar year 2026.


Analysis · HOLX · Industrial Applications And Services

This DEFA14A filing provides crucial clarifications for Hologic employees and shareholders regarding the previously announced acquisition by affiliates of Blackstone Inc. and TPG Capital. It confirms the cash consideration of $76.00 per share plus a Contingent Value Right (CVR) for up to an additional $3.00, contingent on future business performance. The document details the treatment of unvested RSUs and stock options, ensuring transparency for equity holders. While the merger was previously announced, this filing offers definitive operational and financial specifics, reinforcing the terms of the deal as the company approaches its closing.

At the time of this filing, HOLX was trading at $74.86 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $16.7B. The 52-week trading range was $51.90 to $75.34. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOLX - Latest Insights

HOLX
Apr 07, 2026, 9:17 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $76.04
Real-time Price: $76.04 info
Change: $0 (0%) info
Market Cap: $16.969B info
HOLX
Apr 06, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $76.02
Real-time Price: $76.04 info
Change: +$0.0201 (+0.03%) info
Market Cap: $16.969B info
HOLX
Apr 06, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $76.38
Real-time Price: $76.04 info
Change: -$0.3399 (-0.45%) info
Market Cap: $16.969B info
HOLX
Feb 06, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $74.73
Real-time Price: $76.04 info
Change: +$1.31 (+2%) info
Market Cap: $16.969B info
HOLX
Jan 29, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $74.82
Real-time Price: $76.04 info
Change: +$1.22 (+2%) info
Market Cap: $16.969B info